✨ Free AI Report
Takara Bio Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Takara Bio Inc.
Company Research

Takara Bio Inc.: Business Overview, Financials & Competitive Analysis

Takara Bio is a biotechnology company that develops and researches reagents for genome engineering and analysis, the technology used for gene therapy and natural health food products. The company reports in three busi...

Analyst-debate audio for Takara Bio Inc.

AskCyborg analysts argue the bull and bear cases for Takara Bio Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Positioned for growth in expanding gene therapy markets with proprietary platforms and manufacturing infrastructure, though...

Read the full analyst-debate transcript →
Industry Biotechnology & Gene Therapy
3 named competitors
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Takara Bio Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Takara Bio Inc. Overview

Pro stress-test →

Takara Bio is a biotechnology company that develops and researches reagents for genome engineering and analysis, the technology used for gene therapy and natural health food products. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio.

Strategic Profile

Pro stress-test →

Takara Bio became the first company in Japan to conduct clinical trials of gene therapy products in 2008 and entered the CDMO business early, operating the Center for Gene and Cell Processing (CGCP), a large-scale one-stop center for development, manufacturing, and quality testing of gene therapy products. The company develops and delivers products tailored to local researchers through manufacturing centers in the U.S., Europe, China, and India, along with a global sales network.

Competitive Landscape

Pro stress-test →

Takara Bio competes in the biotechnology research reagent and gene therapy manufacturing space against companies like Thermo Fisher, FUJIFILM Cellular Dynamics, and emerging CDMO players. Its competitive advantages include early entry into Japan's gene therapy market, established CDMO infrastructure, and a comprehensive portfolio of research reagents.

Industry Context

Takara Bio Inc. operates in Biotechnology & Gene Therapy.

Key facts

Founded: 2002 · Headquarters: Kusatsu, Japan · Employees: 1,779 · Revenue: $311.7M · Market cap: $891.6M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Takara Bio Inc..

  • Product portfolio includes next generation sequencing, gene function, stem cell research, protein research products, PCR products, and various research reagents and services.
  • The company has built research infrastructure through approximately 10,000 reagents and highly versatile instruments.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Research Reagents & Life Science ToolsGlobal leader in life sciences research reagents and instruments→Cell & Gene Therapy CDMOInduced pluripotent stem cell (iPSC) technology and CDMO services→Gene Therapy SolutionsContract development and manufacturing organization for cell and gene therapies→

Compare Takara Bio Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Takara Bio Inc. operates in Biotechnology & Gene Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology & Gene Therapy research →
NEW · MCP server

Ask your AI assistant about Takara Bio Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Takara Bio Inc. and its top competitor on Cyborg Score”
“What did Takara Bio Inc. do this quarter?”
“Is Takara Bio Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Takara Bio Inc. do?+
Takara Bio is a biotechnology company that develops and researches reagents for genome engineering and analysis, the technology used for gene therapy and natural health food products. The company reports in three busi...
What is Takara Bio Inc.'s Cyborg Score?+
Takara Bio Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Takara Bio Inc.'s main competitors?+
Named competitors include Research Reagents & Life Science Tools, Cell & Gene Therapy CDMO, Gene Therapy Solutions. The full competitive landscape is in the AskCyborg report.
How can I get the full Takara Bio Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Takara Bio Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Takara Bio Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology & Gene Therapy research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Neurogene Inc.7MeiraGTx Holdings plc7REGENXBIO Inc.64D Molecular Therapeutics, Inc.6Voyager Therapeutics, Inc.5Rocket Pharmaceuticals, Inc.